Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1200 of 1329 entries
View as:

Reducing Tobacco Use Disparities Among Low-Income Adults

Phase: N/A Priority: Normal
NCT ID: NCT03077737 Org: User:
Start: 04/21/17 End: 08/31/18 Due: 08/31/19

OTC Hearing Aid and MCI

Phase: N/A Priority: Normal
NCT ID: NCT06112860 Org: User:
Start: 07/23/24 End: 12/31/25 Due: 12/31/26

African-American Social Support Effectiveness Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05762133 Org: User:
Start: 08/27/20 End: 07/31/24 Due: 07/31/25

Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04634799 Org: User:
Start: 01/08/21 End: 05/30/25 Due: 05/30/26

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

Phase: N/A Priority: Normal
NCT ID: NCT06060587 Org: User:
Start: 10/19/23 End: 12/22/30 Due: 12/22/31

Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT04287647 Org: User:
Start: 05/15/19 End: 06/06/26 Due: 06/06/27

Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT02774681 Org: User:
Start: 08/31/16 End: 02/16/20 Due: 02/16/21

Anxiety Lowering and Deprescribing Through Emotion Regulation

Phase: N/A Priority: Normal
NCT ID: NCT06359314 Org: User:
Start: 05/16/24 End: 09/10/24 Due: 09/10/25

An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial

Phase: N/A Priority: Normal
NCT ID: NCT06813898 Org: User:
Start: 02/17/25 End: 02/01/32 Due: 02/01/33

Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use

Phase: N/A Priority: Normal
NCT ID: NCT01200849 Org: User:
Start: 10/31/10 End: 01/31/14 Due: 01/31/15

Patient Navigation 2.0

Phase: N/A Priority: Normal
NCT ID: NCT04234646 Org: User:
Start: 12/09/20 End: 12/31/25 Due: 12/31/26

Quality of Life in Patients With Nonmelanoma Skin Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00518037 Org: User:
Start: 06/30/06 End: 10/31/06 Due: 10/31/07

BRAVO: Biomarker Risk Assessment in Vulnerable Outpatients

Phase: N/A Priority: Normal
NCT ID: NCT02276781 Org: User:
Start: 09/30/09 End: 01/31/13 Due: 01/31/14

Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution

Phase: N/A Priority: Normal
NCT ID: NCT03305159 Org: User:
Start: 08/01/17 End: 04/15/18 Due: 04/15/19

Post Operative Sore Throat and Dexamethasone

Phase: N/A Priority: Normal
NCT ID: NCT01052038 Org: User:
Start: 01/31/10 End: 09/30/10 Due: 09/30/11

Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01166529 Org: User:
Start: 08/31/10 End: 07/31/13 Due: 07/31/14

The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01728636 Org: User:
Start: 01/15/13 End: 12/30/17 Due: 12/30/18

Smartphone Application to Detect Skin Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02740257 Org: User:
Start: 03/31/16 End: 09/02/22 Due: 09/02/23

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02048722 Org: User:
Start: 06/13/14 End: 10/12/21 Due: 10/12/22

Partner Assistance in Learning and Performing Skin Self-Examination

Phase: N/A Priority: Normal
NCT ID: NCT01013844 Org: User:
Start: 12/31/03 End: 11/30/10 Due: 11/30/11

Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)

Phase: N/A Priority: Normal
NCT ID: NCT05942469 Org: User:
Start: 03/18/25 End: 08/31/26 Due: 08/31/27

The Differential Effects of 3 Different Immunosuppressive

Phase: N/A Priority: Normal
NCT ID: NCT00729248 Org: User:
Start: 07/31/08 End: 01/31/10 Due: 01/31/11

ED Physical Therapy for Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT05206630 Org: User:
Start: 01/11/22 End: 07/31/25 Due: 07/31/26

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01163799 Org: User:
Start: 07/31/10 End: 08/31/12 Due: 08/31/13

Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite

Phase: N/A Priority: Normal
NCT ID: NCT02427698 Org: User:
Start: 08/31/15 End: 12/31/25 Due: 12/31/26